Technical Comparison
Apimeds Pharmaceuticals US, Inc. Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between APUS and NVDA.
Primary Asset
APU
Apimeds Pharmaceuticals US, Inc. Common Stock
Market Rank #1005753Live Price$2.71
Market Capitalization$4.1M
24h Change-0.92%
Circulating Supply1.5M APUS
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$186.64
Market Capitalization$4.5T
24h Change+2.78%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | APUS Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1005753 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $2.71 | $186.64 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $4.1M | $4.5T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Apimeds Pharmaceuticals US, Inc. Common Stock bigger than NVIDIA Corporation - Common Stock?
Apimeds Pharmaceuticals US, Inc. Common Stock has a market cap of $4.1M, while NVIDIA Corporation - Common Stock sits at $4.5T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Apimeds Pharmaceuticals US, Inc. Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 APUS is worth 0.01 NVDA.